首页> 外国专利> Antibodies against phosphorylcholine in combination therapy with biologic agents

Antibodies against phosphorylcholine in combination therapy with biologic agents

机译:与生物制剂联合治疗的抗磷酸胆碱抗体

摘要

#$%^&*AU2017200389B220180531.pdf#####ABSTRACT Antibodies against PC, PC conjugate or bioactive components and/or fragments thereof for use in combination therapy with one or more biologic agents and/or 5 stem cells are disclosed, as well as compositions comprising the antibodies in combination with one or more biologic agents and/or stem cells. Also disclosed are PC conjugates, PC or bioactive components and/or parts/fragments thereof for use in activation immunotherapy prior to or in combination with treatment with biologic agents and/or stem cells for curing, treating, preventing, and/or 10 reducing the risk of developing auto-immune diseases, chronic inflammatory diseases, and cancer diseases, as well as compositions comprising them in combination with biologic agents and/or stem cells.
机译:#$%^&* AU2017200389B220180531.pdf #####抽象抗PC,PC共轭物或生物活性成分和/或片段的抗体其与一种或多种生物剂和/或组合治疗中使用公开了5种干细胞,以及包含该抗体的组合物与一种或多种生物制剂和/或干细胞的组合。还公开了是PC共轭物,PC或生物活性成分和/或其零件/片段在治疗之前或与治疗结合用于激活免疫治疗与生物制剂和/或干细胞一起治疗,治疗,预防和/或治疗10降低发展自身免疫疾病,慢性炎症的风险疾病,癌症疾病以及包含它们的组合物与生物制剂和/或干细胞结合使用。

著录项

  • 公开/公告号AU2017200389B2

    专利类型

  • 公开/公告日2018-05-31

    原文格式PDF

  • 申请/专利权人 ATHERA BIOTECHNOLOGIES AB;

    申请/专利号AU20170200389

  • 发明设计人 FROSTEGARD JOHAN;

    申请日2017-01-20

  • 分类号C07K16/18;G01N33/564;G01N33/68;

  • 国家 AU

  • 入库时间 2022-08-21 12:45:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号